United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 4 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for FONAR CORP? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | |||
|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | 4.92% | 4.45% | 4.96% | 4.36% | 4.23% |
|---|---|---|---|---|---|
| ROA | 3.87% | 3.52% | 3.87% | 3.36% | 3.2% |
| Gross Margin | 100% | 88.5% | 88.35% | 88.2% | 87.76% |
| Net Margin | 7.99% | 6.71% | 7.14% | 6.11% | 5.82% |
| Total Assets | $216,908.00K | $229,916.30K | $243,981.50K | $259,148.16K | $275,185.29K |
| Net Income | $8,334.26K | $7,862.05K | $9,180.98K | $8,451.08K | $8,555.37K |